Cowen Prime Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,000
Closed -$38K 223
2016
Q3
$38K Hold
1,000
0.02% 177
2016
Q2
$42K Hold
1,000
0.02% 152
2016
Q1
$40K Hold
1,000
0.02% 152
2015
Q4
$43K Hold
1,000
0.02% 149
2015
Q3
$47K Hold
1,000
0.02% 156
2015
Q2
$50K Hold
1,000
0.02% 160
2015
Q1
$49K Hold
1,000
0.02% 182
2014
Q4
$46K Hold
1,000
0.02% 199
2014
Q3
$56K Hold
1,000
0.02% 178
2014
Q2
$53K Hold
1,000
0.02% 170
2014
Q1
$52K Hold
1,000
0.02% 168
2013
Q4
$54K Hold
1,000
0.02% 175
2013
Q3
$51K Hold
1,000
0.02% 184
2013
Q2
$52K Buy
+1,000
New +$53.3K 0.02% 174

Other funds holding SNY

Cowen Prime Advisors's SNY Position: Q4 2016 in Review

Cowen Prime Advisors sold out of Sanofi (SNY) in Q4 2016, closing a stake of 1,000 shares — an estimated $38K sold.

Cowen Prime Advisors first reported a position in SNY in Q2 2013 and held it in 14 quarters. The position peaked at $56K in Q3 2014. 476 funds tracked by Wall St. Rank hold SNY as of Q4 2016.

  • Cowen Prime Advisors reported no remaining Sanofi position as of Q4 2016 after selling out during the quarter.
  • Cowen Prime Advisors sold 1,000 Sanofi shares in Q4 2016, an estimated $38K.
  • Cowen Prime Advisors first reported a position in Sanofi in Q2 2013 and held it in 14 quarters.
  • Cowen Prime Advisors's Sanofi position peaked at $56K in Q3 2014.
  • 476 funds tracked by Wall St. Rank held Sanofi as of Q4 2016.

Based on Cowen Prime Advisors's 13F filing for Q4 2016, filed 9 Feb 2017.